After reaching an important support level, Xilio Therapeutics, Inc. (XLO) could be a good stock pick from a technical perspective. XLO recently experienced a "golden cross" event, which saw its 50 ...

On Wednesday, AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to develop novel tumor-activated, antibody-based ...

Short interest in Xilio Therapeutics Inc (NASDAQ:XLO) decreased during the last reporting period, falling from 384.09K to 213.07K. This put 0.56% of the company's publicly available shares short.

Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie Inc. (ABBV). Xilio Targeting Range of Cancers The two companies announced ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ocugen (OCGN – Research Report) and Xilio Therapeutics (XLO – Research Report) with bullish ...

Find the latest Xilio Therapeutics, Inc. XLO analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.